Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Protein kinase C modulators in the pipeline at Procyon

April 5, 1996

Antineoplastic fusion proteins from Bristol-Myers Squibb

April 5, 1996

BMS reports mutant BR96 antibodies

April 5, 1996

PPI-149 selected for development

April 5, 1996

Sparta develops new formulations of taxanes

April 5, 1996

Roussel Morishita reports new aromatase inhibitor

April 5, 1996

Boehringer Mannheim synthesizes antitumor anthrapyrazoles

April 5, 1996

Yakult Honsha claims camptothecin derivatives

April 5, 1996

Sparta to develop new camptothecin formulations

April 5, 1996

New daunorubicin derivative from P&U

April 5, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...